United States · 
Who invested in Evolve BioSystems?
Evolve BioSystems's investors include Horizons Ventures, Bow Capital, ACRE, Tate & Lyle and Gates Foundation, and 9 more on record.
201620172018201920202021
$9.0MSeries A$20MSeries B$40MSeries C$55MSeries D
United States · Series D startup
Who invested in Evolve BioSystems
Funding summaryUpdated 26 Oct 2026
$124Mraised across 4 rounds since 2015, from 4 sources
$9.0MSeries A$20MSeries B$40MSeries C$55MSeries D
- Latest round
- Series D, $55MFeb 2021
- Step-upi
- 1.4×
- Investors
- 14
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $9.0M Aug 2015
- Biggest round
- $55M Series D · Feb 2021
- Usual gap between rounds
- 21 months the median of 3
The rounds
- Feb 2021
- Jun 2018Series C$40M7 new4 returning
Horizons Ventures
Gates Foundation- JJDC
- Li Ka-shing
Bow Capital
Alta
ACRE
Spruce
Tate & Lyle- Arla Foods
- Continental Grain
Reported by FinSMEs
- May 2017
- Aug 2015Series A$9.0M2 new
From a historical funding recordSEC filing: $9.0M sold, first sale Jul 2015
Founders and team
From Evolve BioSystems's own website and the SEC filings it signed: 20 on the team.
- Mike JohnsonChief Executive Officer
- Craig PensabeneVice President, Growth
- Jennifer Van AkenSenior Vice President, Marketing
- Arlene FosmerChief Science Officer
- Christian BloomgrenChief Commercial Officer
- Mandy KennedyChief Commercial Officer & Chief of Staff
- Patrick CormierChief Financial Officer
- Britta HeissVP - R&D
- Amanda TrovatoQuality Systems and Controls Manager
- Derek GordonDirector, Business Analytics & Operations
- Fei MacLeodDirector, Brand Marketing
- Iris StreimishDirector, Clinical Implementation
- Lizabeth KurjiakaDirector, Strategic Product Lead
- Melanie McNicholDirector, Commercial Marketing
- Morgan StokesExecutive Director of Clinical Operations
- Sabrina SamsonDirector, Marketing
- David J. KyleExecutive Officer, Directori
- David J. MillsExecutive Officeri
And 2 more on the team.
On the board, as filediAnne Bruce LoCatherine Bruce MackeyDaniel Bruce JanneyJ. Bruce GermanSimon Bruce Barnes
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2015Series B2017Series C2018Series D2021Horizons VenturesBow CapitalACRETate & LyleGates FoundationJJDCLi Ka-shing
Tate & Lyle VenturesAltaSpruce
Horizons VenturesBow CapitalACRETate & LyleGates FoundationJJDCLi Ka-shingTate & Lyle VenturesAltaSpruceEveryone who backed them
JJDCInvestment firm1round
Li Ka-shingAngel1round
Arla Foodsno record of our own yet1round
Continental Grainno record of our own yet1round
MLS/ Horizonsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Evolve BioSystems
How much has Evolve BioSystems raised?
Evolve BioSystems has raised $124M across 4 rounds since 2015.
When did Evolve BioSystems last raise?
Evolve BioSystems's most recent round was a Series D of $55M in Feb 2021.
What was Evolve BioSystems's biggest round?
Its most recent round, $55M in Feb 2021, is also its largest on record.
Who backed Evolve BioSystems first?
Evolve BioSystems's first round on record, in Aug 2015, was backed by Horizons Ventures and Tate & Lyle Ventures.
What stage is Evolve BioSystems at?
Evolve BioSystems's latest named round is a Series D, in Feb 2021.
Where is Evolve BioSystems based?
Evolve BioSystems is based in the United States.
Companies like Evolve BioSystems
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.